Abstract:Enterotoxigenic Escherichia coli (ETEC) strains that produce immunologically heterogeneous fimbriae and enterotoxins are the primary cause of neonatal diarrhea and postweaning diarrhea in young pigs. A multivalent vaccine inducing protective immunity against ideally all ETEC fimbriae and enterotoxins could be effective against diarrhea in young pigs. However, developing a vaccine to broadly protect against various ETEC virulence determinants has proven challenging. Recently developed structure- and epitope-based multiepitope fusion antigen (MEFA) technology that presents neutralizing epitopes of various virulence determinants at a backbone immunogen and that mimics epitope native immunogenicity suggests the feasibility of developing multivalent vaccines. With neutralizing epitopes from ETEC fimbria F18 and enterotoxins being identified, it becomes urgent to identify protective epitopes of K88 (F4) fimbriae, which play a major role in pig neonatal and postweaning diarrhea. In this study, we identified B-cell immunodominant epitopes in silico from the K88ac fimbrial major subunit (also adhesin) FaeG and embedded each epitope in a heterogeneous carrier for epitope fusions. We then immunized mice with each epitope fusion protein and examined epitope antigenicity and also neutralizing activities of epitope-induced antibodies. Data showed that while all nine FaeG epitope fusions induced antibodies to K88ac fimbria, anti-K88 IgG antibodies derived from epitopes MTGDFNGSVD (ep1), LNDLTNGGTK (ep2), GRTKEAFATP (ep3), ELRKPDGGTN (ep4), PMKNAGGTKVGAVKVN (ep5), and RENMEYTDGT (ep8) significantly inhibited adherence of K88ac fimbrial bacteria to porcine intestinal cell line IPEC-J2, indicating that these peptides were the neutralizing epitopes of K88ac fimbrial major subunit FaeG and suggesting the future application of FaeG epitopes in ETEC vaccine development. IMPORTANCE Enterotoxigenic Escherichia coil (ETEC) strains producing K88ac fimbriae and enterotoxins are a major cause of porcine neonatal diarrhea and postweaning diarrhea in the United States. Currently, there is no vaccine to induce broadly protective antiadhesin and antitoxin immunity against ETEC-associated diarrhea. To develop a broadly effective ETEC vaccine, we need to target the most important if not all ETEC virulence determinants. While conventional vaccinology approaches encounter difficulties at integrating or including heterogeneous ETEC fimbria and toxin antigens into a vaccine product, multiepitope fusion antigen (MEFA) structural vaccinology provides a new platform to combine neutralizing antigenic elements or epitopes from various heterogeneous virulence factors for broad immunity and protection. Identification of the neutralizing epitopes of K88ac fimbria from this study added the last antigens to an MEFA-based multivalent vaccine against ETEC-associated diarrhea in pigs. An effective vaccine against pig diarrhea can significantly improve swine health and well-being and reduce economic losses to the swine industry worldwide.

Progress and Challenges in Vaccine Development Against Enterotoxigenic Escherichia Coli (Etec)-Associated Porcine Post- Weaning Diarrhoea (PWD)

Application of a Novel Epitope- and Structure-Based Vaccinology-Assisted Fimbria-Toxin Multiepitope Fusion Antigen of Enterotoxigenic Escherichia Coli for Development of Multivalent Vaccines Against Porcine Postweaning Diarrhea

Progress and Hurdles in the Development of Vaccines Against Enterotoxigenicescherichia Coliin Humans

Genetic Fusions of Heat-Labile Toxoid (lt) and Heat-Stable Toxin B (stb) of Porcine Enterotoxigenic Escherichia Coli Elicit Protective Anti-Lt and Anti-Stb Antibodies

Current Progress in Developing Subunit Vaccines Against Enterotoxigenic Escherichia Coli-Associated Diarrhea

Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection

Mapping the neutralizing epitopes of enterotoxigenic (ETEC) K88 (F4) fimbrial adhesin and major subunit FaeG.

Research Progress on ETEC Vaccines against Piglet Diarrhea

Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli

Prevalence of virulence genes in Escherichia coli strains recently isolated from young pigs with diarrhea in the US.

Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate

Protective Efficacy of a Novel Multivalent Vaccine in the Prevention of Diarrhea Induced by Enterotoxigenic Escherichia Coli in a Murine Model

Protective Immunity of a Multivalent Vaccine Candidate Against Piglet Diarrhea Caused by Enterotoxigenic Escherichia Coli (ETEC) in a Pig Model.

Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine Development

Significance of Heat-Stable and Heat-Labile Enterotoxins in Porcine Colibacillosis in an Additive Model for Pathogenicity Studies

Evaluation of the prophylactic potential of non-enterotoxigenic Escherichia coli (non-ETEC) vaccine immunization and dietary mannan oligosaccharide competitive exclusion benefits against ETEC infections in weaned pigs

Production of a new tetravalent vaccine targeting fimbriae and enterotoxin of enterotoxigenic Escherichia coli

[Advances in new vaccines against human enterotoxigenic Escherichia coli--A review]

Status of vaccine research and development for enterotoxigenic Escherichia coli

Engineered Recombinant Escherichia Coli Probiotic Strains Integrated with F4 and F18 Fimbriae Cluster Genes in the Chromosome and Their Assessment of Immunogenic Efficacy in Vivo.

A Multivalent Vaccine Candidate Targeting Enterotoxigenic Escherichia Coli Fimbriae for Broadly Protecting Against Porcine Post-Weaning Diarrhea